Thus, in one prospective study, 323 patients with type 2 diabetes uncontrolled on metformin plus liraglutide (baseline HbA1c, 7.6%) were randomised to add-on insulin detemir (n = 162) or continuation without insulin detemir (n = 161). Here, INS is linked to type 2 diabetes mellitus.